-
April 2026: This Month in Huntington’s Disease Research
Latest News
-
Turning skin cells into brain cells: a Huntington's disease research breakthrough?
Scientists can now change human skin cells into working neurons, like the ones that are most affected in HD.
-
Huntington's disease clinical trial announcement: huntingtin-lowering drug to enter Phase I trial in 2015
A clinical trial for an exciting therapy against HD is planned for 2015. The first step is to make sure it is safe.
-
Largest creatine clinical trial for Huntington's disease halted after 'futility' analysis
CREST-E, a trial of the supplement creatine, has been stopped after an early analysis found it couldn't show benefit
-
Should we worry about a huntingtin invasion?
Cool lab experiments show the huntington's disease protein jumping between cells. Does this matter for HD patients?
-
EuroBuzz 2014 Video, day one
Video of our first live session at the European Huntington's Disease Network Meeting.
-
EuroBuzz 2014 Video, day two
Video of our second live session at the European Huntington's Disease Network Meeting.
-
Melatonin alterations in Huntington's disease help explain trouble with sleep
Study shows HD patients have decreased levels of melatonin, which may explain why so many suffer from sleep problems
-
EuroBuzz 2014: day three
Our third and final report on the 2014 European Huntington's Disease Network meeting in Barcelona
-
EuroBuzz 2014: day two
HDBuzz reports on the second day of science at the European HD Network meeting in Barcelona
-
EuroBuzz 2014: day one
Highlights from the opening day of the 2014 European Huntington's Disease network in Barcelona, Spain
HDBuzz Trial Tracker
Sites for Phase 3 trial for votoplam, INVEST-HD, now open. Updates on recruitment and first dosing imminent.
Progress update for NCT06585449 – A Study to Evaluate ALN-HTT02
